X’s Location Feature Stirs Uproar & Novo Nordisk Tanks After Failed Alzheimer’s Trial

Episode 721: Neal and Toby chat about X’s new location transparency feature that has opened up a can of worms as some of the most divisive accounts on US politics aren’t actually from the US. Then, Novo Nordisk has taken a big hit after its trials to develop a drug to delay Alzheimer’s have failed. Plus, the Trump administration makes access to federal student loans stricter, particularly for nurses. Meanwhile, is cigarette smoking cool again?  Learn more at usbank.com/splitcard  Get your MBD live show tickets here! https://www.tinyurl.com/MBD-HOLIDAY  Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app. Listen to Morning Brew Daily Here:⁠ ⁠⁠https://www.swap.fm/l/mbd-note⁠⁠⁠  Watch Morning Brew Daily Here:⁠ ⁠⁠https://www.youtube.com/@MorningBrewDailyShow⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.